Mereo BioPharma Cash Flow Statement (2020-2025) | MREO

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -12.08M-1.75M-6.53M-9.11M-8.95M-12.26M-15.00M-7.05M-12.89M-14.62M-7.02M
Depreciation and Depletion 0.04M0.10M0.10M0.07M0.04M0.10M0.10M0.04M0.04M0.04M0.04M
Share-based Compensation 1.64M0.94M1.53M0.81M2.05M2.09M1.74M1.51M2.28M2.06M1.71M
Gains from Sales and Divestitures -0.07M0.50M0.14M0.80M1.34M1.34M
Gains from Investment Securities -0.54M0.10M-0.90M0.45M0.07M0.06M-2.33M-0.42M0.10M-0.20M
Non-cash Items 0.01M8.12M17.35M18.98M23.87M15.76M6.96M10.05M4.84M
Cash from Operations -9.25M-7.75M2.66M-6.79M-7.99M-7.90M-7.52M-9.42M-8.33M-7.65M-7.31M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.12M0.12M0.13M0.12M0.13M0.13M0.13M0.13M0.13M0.14M0.13M
Amortization 82.80M91.58M168.20M133.89M103.02M
Depreciation & Amortization (CF) 0.04M0.10M0.10M0.07M0.04M0.10M0.10M0.04M0.04M0.04M0.04M
Change in Working Capital
Change in Account Payables 0.81M-2.31M-0.76M0.99M0.13M0.24M-1.06M0.84M0.36M-1.95M-0.24M
Change in Accured Expenses -3.10M-1.71M-2.94M3.25M-0.79M-0.71M-1.39M1.93M-0.67M
Investing Activities
Capital Expenditures 0.02M
Change in Intangibles 0.42M0.70M-0.00M0.30M
Cash from Investing Activities -0.42M-0.70M0.00M-0.32M0.30M
Financing Activities
Other financing activities 0.48M0.22M0.59M0.04M0.07M0.13M
Change in Capital Stock
Shares Issued 11.51M47.00M0.49M
Misc.
Cash from Financing Activities 7.91M46.78M-0.59M-0.04M0.42M-0.13M
Exchange Rate Effect 1.29M0.85M-1.00M1.68M-0.07M-0.11M1.20M-1.26M0.91M1.43M-0.42M
Change in Cash -9.67M-7.69M11.70M-5.11M-8.69M38.88M-8.11M-9.69M-8.23M-7.79M-7.01M
Free Cash Flow -9.25M-7.75M2.66M-6.79M-7.99M-7.90M-7.52M-9.42M-8.35M-7.65M-7.31M
Net Cash Flow -9.67M-7.75M10.56M-6.79M-8.69M38.88M-8.11M-9.46M-8.23M-7.79M-7.01M